US hospitals using HCQ in treatment of COVID 19 patients
MDedge, a medical publication, on Friday reported that hydroxychloroquine (HCQ) is currently the first-line therapy and Tocilizumab the second-line medication for people hospitalized with polymerase chain reaction-confirmed COVID-19 infection in the Yale New Haven Health System, which operates hospitals across Connecticut.By May 02, 2020 at 10:24AM
No comments